Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Effectiveness, Safety and Tolerability of Various Doses of Linezolid in Combination With Bedaquiline and Pretomanid in Adults With Pre-Extensively Drug-Resistant (Pre-XDR), Or Treatment Intolerant/Non-responsive Multidrug-Resistant (MDRTI/NR) Pulmonary Tuberculosis in India

NCT05040126 is registered in ClinicalTrials.gov with Tuberculosis Research Centre, India as lead sponsor.

NCT NCT05040126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Effectiveness, Safety and Tolerability of Various Doses of Linezolid in Combination With Bedaquiline and Pretomanid in Adults With Pre-Extensively Drug-Resistant (Pre-XDR), Or Treatment Intolerant/Non-responsive Multidrug-Resistant (MDRTI/NR) Pulmonary Tuberculosis in India
Lead sponsor
Tuberculosis Research Centre, India
Phase
Phase 3
Overall status
Unknown status
Start date
October 7, 2021
Completion date
December 31, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-responsive multidrug-resistant pulmonary tb, pre-extensively drug-resistant pulmonary tb, treatment intolerant multidrug-resistant pulmonary tb